BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15531466)

  • 1. Prognostic significance of N-RAS and K-RAS mutations in 232 patients with acute myeloid leukemia.
    Ritter M; Kim TD; Lisske P; Thiede C; Schaich M; Neubauer A
    Haematologica; 2004 Nov; 89(11):1397-9. PubMed ID: 15531466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia.
    Preston R; Däbritz J; Hänfler J; Oettle H
    Leuk Res; 2010 Jul; 34(7):883-91. PubMed ID: 20304488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
    Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
    Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K-Ras mutations and N-Ras mutations in childhood acute leukemias with or without mixed-lineage leukemia gene rearrangements.
    Liang DC; Shih LY; Fu JF; Li HY; Wang HI; Hung IJ; Yang CP; Jaing TH; Chen SH; Liu HC
    Cancer; 2006 Feb; 106(4):950-6. PubMed ID: 16404744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation.
    Yoshimoto G; Nagafuji K; Miyamoto T; Kinukawa N; Takase K; Eto T; Kato K; Hayashi S; Kamimura T; Ohno Y; Taniguchi S; Harada M
    Bone Marrow Transplant; 2005 Dec; 36(11):977-83. PubMed ID: 16184177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.
    Auewarakul CU; Lauhakirti D; Tocharoentanaphol C
    Eur J Haematol; 2006 Jul; 77(1):51-6. PubMed ID: 16573741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation of activating Ras/rtk signal transduction pathway mutations and inactivating myeloid differentiation gene mutations in M0 AML: a study of 45 patients.
    Roumier C; Lejeune-Dumoulin S; Renneville A; Goethgeluck AS; Philippe N; Fenaux P; Preudhomme C
    Leukemia; 2006 Mar; 20(3):433-6. PubMed ID: 16424869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras gene mutations in patients with acute myeloid leukaemia and exposure to chemical agents.
    Barletta E; Gorini G; Vineis P; Miligi L; Davico L; Mugnai G; Ciolli S; Leoni F; Bertini M; Matullo G; Costantini AS
    Carcinogenesis; 2004 May; 25(5):749-55. PubMed ID: 14688017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RAS, FLT3, and C-KIT mutations in immunophenotyped canine leukemias.
    Usher SG; Radford AD; Villiers EJ; Blackwood L
    Exp Hematol; 2009 Jan; 37(1):65-77. PubMed ID: 18977066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is FLT3 internal tandem duplication significant indicator for allogeneic transplantation in acute myeloid leukemia? An analysis of patients from the Czech Acute Leukemia Clinical Register (ALERT).
    Doubek M; Muzík J; Szotkowski T; Koza V; Cetkovský P; Kozák T; Zák P; Voglová J; Struncová S; Dusek L; Indrák K
    Neoplasma; 2007; 54(1):89-94. PubMed ID: 17233551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations and expression of the ras family genes in leukemias.
    Gougopoulou DM; Kiaris H; Ergazaki M; Anagnostopoulos NI; Grigoraki V; Spandidos DA
    Stem Cells; 1996 Nov; 14(6):725-9. PubMed ID: 8948029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct gene expression patterns associated with FLT3- and NRAS-activating mutations in acute myeloid leukemia with normal karyotype.
    Neben K; Schnittger S; Brors B; Tews B; Kokocinski F; Haferlach T; Müller J; Hahn M; Hiddemann W; Eils R; Lichter P; Schoch C
    Oncogene; 2005 Feb; 24(9):1580-8. PubMed ID: 15674343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myeloid leukaemia with FLT3 gene mutations of both internal tandem duplication and point mutation type.
    Chen W; Jones D; Medeiros LJ; Luthra R; Lin P
    Br J Haematol; 2005 Sep; 130(5):726-8. PubMed ID: 16115128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
    Palmieri S; Ferrara F; Leoni F; Ciolli S; Pollio F; D'Amico MR; Celentano M; Viola A; Vicari L; Izzo B; Pane F
    Hematol Oncol; 2007 Mar; 25(1):1-5. PubMed ID: 17036374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: study of 77 Greek patient.
    Speletas M; Arvanitidi K; Tzoanopoulos D; Tsironidou V; Pardali E; Aggeli C; Tsapogas P; Kartalis G; Sideras P; Ritis K
    Haematologica; 2001 Sep; 86(9):918-27. PubMed ID: 11532619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
    Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific detection of Flt3 point mutations by highly sensitive real-time polymerase chain reaction in acute myeloid leukemia.
    Scholl S; Krause C; Loncarevic IF; Müller R; Kunert C; Wedding U; Sayer HG; Clement JH; Höffken K
    J Lab Clin Med; 2005 Jun; 145(6):295-304. PubMed ID: 15976757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.
    Georgiou G; Karali V; Zouvelou C; Kyriakou E; Dimou M; Chrisochoou S; Greka P; Dufexis D; Vervesou E; Dimitriadou E; Efthymiou A; Petrikkos L; Dima K; Lilakos K; Panayiotidis P
    Br J Haematol; 2006 Aug; 134(3):302-6. PubMed ID: 16787503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of conservative RAS mutations in acute myeloid leukemia.
    Aurer I; Labar B; Nemet D; Ajduković R; Bogdanić V; Gale RP
    Acta Haematol; 1994; 92(3):123-5. PubMed ID: 7871950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ras oncogene activation and occupational exposures in acute myeloid leukemia.
    Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E
    J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.